Paraskevis, Dimitrios
,
Beloukas, Apostolos http://orcid.org/0000-0001-5639-0528
Stasinos, Kostantinos
Pantazis, Nikos
de Mendoza, Carmen
Bannert, Norbert
Meyer, Laurence
Zangerle, Robert
Gill, John
Prins, Maria
d’Arminio Montforte, Antonella
Kran, Anne-Marte Bakken
Porter, Kholoud
Touloumi, Giota
Funding for this research was provided by:
European Union Seventh Framework Programme (260694)
ΙΚΥ Postdoc Research Grants
Article History
Received: 27 February 2018
Accepted: 14 December 2018
First Online: 8 January 2019
Ethics approval and consent to participate
: List of approval numbers/references from all participating cohorts:Austrian participating centres: Ethikkommission der Medizinische Universitat Graz (21-431 ex09/10); Ethikkommission der Medizinischen Universitat Innsbruck (283/4.4); Ethikkommission des Landes Oberosterreich (C-3-10); Ethikkommission fur das Bundesland Salzburg (415-E/1159/4-2010); Ethikkommission der Medizinischen Universitat Wien (898/2010).Canada registry: University of Calgary Medical Bioethics committee, Calgary Alberta Canada (REB15-0929_REN4 2).French cohort: Comite de protection des Personnes ile de France II (Am7323-13-1157).German HIV-1 Seroconverter Cohort: The ethical committee of the Charité University Medicine Berlin (EA2/105/05).Greek cohort (AMACS – Athens Multicenter AIDS Cohort Study): The Hellenic Center for Diseases Control and Prevention (4090/2005); Athens University Medical School EC (319/2005) and the National Organization of Medicines (NIS-23-01-05/ 2006).Italian cohort: Local ethical committees from all sites contributing to the cohort (10/08/69/07 AP; 348/L; 1932; 261/07/CE; 0132246/67GP; 115/2007; V2016; 44 CE/MA/CM; 63687; 98/07; RP/246/CE; 29/CE; 111/350; 857/D; 26547; 217/CEP; 51460; 5522/08-RN/RV; 1926/32/07; 42847; 125/2007/0/OSS; 24781; 3811/AO/16; 3039/CE; 2070211; 60/INT/CEI/11263; 006; 589/A1376/CE/2007; 38/2007; 1296/08; 35-2016; 1272; CE/38/14; 263/CELAZIO1; 3617; 7925/16; 32/2007; 7713/R; 20/16).Netherlands registry: the Medical Ethical Committee of the Amsterdam Medical Centre, the Netherlands (07/182 and 09/040).Norwegian cohort: Regionale Komiteer for Medisinsk og Helsefaglig Forskningstetikk (REK) (2016/892/REK; 1.2006.1811 - S-0885).Spain cohort: Comité de Ética de la Investigación y de Bienestar Animal del Instituto de Salud Carlos III (ISCIII) (CEI PI 01_2012-v2).UK registry: The West Midlands – South Birmingham National Research Ethics Service (04/G2707/155).Enrolled study patients gave written informed consent. A full list of the ethics committees that provided approval can be found in the in Additional file InternalRef removed.
: Not applicable.
: AB received an ΙΚΥ Fellowship of Excellence for Postdoctoral Research in Greece – Siemens Program for this work. LM has received grants from ANRS, Fondation de la Recherche Médicale, and the European Union (EU) Framework Programme 7 (FP7) through the Medical Research Council–University College London (UCL), UK, outside of the submitted work. JG has received honoraria as an ad hoc member of the national HIV advisory boards of Merck, Gilead and ViiV, outside of the submitted work. KP received funding from EU FP7 while conducting this study, as well as honoraria from ViiV Healthcare and Merck, Sharp and Dohme, outside of the submitted work. GT received funding from the EU while conducting this study, as well as grants from the European Centre for Disease Prevention and Control, the EU, UCL, EU structural funds and National Funds and Gilead Sciences Europe, outside of the submitted work. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.